Substituted 2-aminoacetamides and the use thereof

Details Substituted 2-aminoacetamides and the use thereof Substituted 2-aminoacetamides and the use thereof

2006-08-15

2006-08-15

Spivack, Phyllis G. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S312000, C514S318000, C514S332000, C514S311000, C514S269000, C514S256000

Reexamination Certificate

active

07091210

ABSTRACT:
The invention is directed to substituted 2-aminoacetamides represented by formula (II):and to pharmaceutically acceptable salts thereof, wherein the substituents are defined herein, for use in the treatment or amelioration of pain.

REFERENCES:
patent: 3576864 (1971-04-01), Kuppaswamy
patent: 4725608 (1988-02-01), Nakaguchi et al.
patent: 4927835 (1990-05-01), Kise et al.
patent: 5236957 (1993-08-01), Dostert et al.
patent: 5446066 (1995-08-01), Varasi et al.
patent: 5449692 (1995-09-01), Varasi et al.
patent: 5475007 (1995-12-01), Cai et al.
patent: 5482964 (1996-01-01), Hays
patent: 5498610 (1996-03-01), Chenard
patent: 5741818 (1998-04-01), Dimmock
patent: 5849373 (1998-12-01), Barbour et al.
patent: 5945454 (1999-08-01), Pevarello et al.
patent: 6281211 (2001-08-01), Cai et al.
patent: 6306903 (2001-10-01), Pevarello et al.
patent: WO 90/14334 (1990-11-01), None
patent: WO 96/40628 (1996-12-01), None
patent: WO 97/05102 (1997-02-01), None
patent: WO 98/19998 (1998-05-01), None
patent: WO 98/43964 (1998-10-01), None
patent: WO 98/47869 (1998-10-01), None
patent: WO 99/39712 (1999-08-01), None
Anonymous, “Neurogen licenses National Institutes of Health (NIH) anticonvulsants,”SCRIP World Pharmaceutical News 1773:14, PJB Publications Ltd. (1992).
Anonymous, “Cambridge NeuroScience's grant for channel blockers,”SCRIP World Pharmaceutical News 1870:8, PJB Publications Ltd. (1993).
Bensimon, G., et al., “A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis,”New Engl. J. Med. 330:585-591, Massachusetts Medical Society (1994).
Brown, C.M., et al., “Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia,”British J. Pharmacol. 115:1425-1432, Stockton Press (1995).
Catterall, W.A., “Neurotoxins That Act on Voltage-Sensitive Sodium Channels in Excitable Membranes,”Ann. Rev. Pharmacol. Toxicol. 20:15-43, Annual Review Inc. (1980).
Catterall, W.A., “Common modes of drug action on Na+Channels: local anesthetics, antiarrhythmics and anticonvulsants,”Trends Pharmacol. Sci. 8:57-65, Elsevier Science Ltd. (1987).
Catterall, W.A., “Structure and Function of Voltage-Sensitive Ion Channels,”Science 242:50-61, American Association for the Advancement of Science (1988).
Denicoff, K.D., et al., “Efficacy of Carbamazepine Compared With Other Agents: A Clinical Practice Survey,”J. Clin. Psychiatry 55:70-76, Physicians Postgraduate Press (1994).
Dimmock, J.R., et al., “(Aryloxy)aryl Semicarbazones and Related Compounds: A Novel Class of Anticonvulsant Agents Possessing High Activity in the Maximal Electroshock Screen,”J. Med. Chem. 39:3984-3997, American Chemical Society (1996).
Graham, S.H., et al., “Neuroprotective Effects of a Use-Dependent Blocker of Voltage-Dependent Sodium Channels, BW619C89, in Rat Middle Cerebral Artery Occlusion,”J. Pharmacol. Exp. Ther. 269:854:-859, American Society of Pharmacology Experimental Therapeutics (1994).
Pevarello, P., et al., “Synthesis and Anticonvulsant Activity of a New Class of 2-[(Arylalkyl)amino]alkanamide Derivatives,”J. Med. Chem. 41:579-590, American Chemical Society (1998).
Stys, P.K., et al., “Ionic Mechanisms of Anoxic Injury in Mammalian CNS White Matter: Role of Na+Channels and Na+-Ca2+Exchanger,”J. Neurosci. 12:430-439, Society for Neuroscience (1992).
Taylor, C.P. and Meldrum, B.S., “Na+channels as targets for neuroprotective drugs,”Trends Pharmacol. Sci. 16:309-316, Elsevier Science Ltd. (1995).

Affiliated with

Also associated with

Rating

Substituted 2-aminoacetamides and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 2-aminoacetamides and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-aminoacetamides and the use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3669674